Enzymatica publ AB Cash Flow Conversion Efficiency

Latest as of September 2025: -0.085x

Enzymatica publ AB cash flow conversion efficiency. Based on the latest financial reports, Enzymatica publ AB (ENZY) has a cash flow conversion efficiency ratio of -0.085x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.57 Million ≈ $-1.24 Million USD) by net assets (Skr135.68 Million ≈ $14.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Enzymatica publ AB (2009–2024)

Cash flow conversion efficiency of Enzymatica publ AB from 2009 to 2024. This chart illustrates how Enzymatica publ AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ENZY stock price and chart for real-time trading data and today's change.

Enzymatica publ AB Cash Flow Conversion Ratio Explained

Enzymatica publ AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Enzymatica publ AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Enzymatica publ AB ranked by their cash flow conversion efficiency. Also see ENZY market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mandom Indonesia Tbk JK:TCID	0.032x
Yunsa Yunlu Sanayi ve Ticaret AS IS:YUNSA	0.030x
Grupo Mexicano de Desarrollo S.A.B MX:GMD	0.005x
Comet Ridge Ltd AU:COI	-0.023x
DrayTek Corp TW:6216	0.002x
UY Scuti Acquisition Corp. NASDAQ:UYSC	N/A
WASGAU Produktions & Handels AG F:MSH	0.064x
Samart Telcoms Public Company Limited BK:SAMTEL	0.208x

Annual Cash Flow Conversion Efficiency for Enzymatica publ AB (2009–2024)

The table below shows the annual cash flow conversion efficiency of Enzymatica publ AB from 2009 to 2024. Review how much free cash does Enzymatica publ AB generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr176.37 Million ≈ $18.98 Million	Skr-60.51 Million ≈ $-6.51 Million	-0.343x	+34.76%
2023-12-31	Skr76.61 Million ≈ $8.24 Million	Skr-40.29 Million ≈ $-4.34 Million	-0.526x	-2.86%
2022-12-31	Skr126.29 Million ≈ $13.59 Million	Skr-64.57 Million ≈ $-6.95 Million	-0.511x	-78.12%
2021-12-31	Skr124.97 Million ≈ $13.45 Million	Skr-35.87 Million ≈ $-3.86 Million	-0.287x	-187.36%
2020-12-31	Skr106.65 Million ≈ $11.48 Million	Skr-10.65 Million ≈ $-1.15 Million	-0.100x	+68.32%
2019-12-31	Skr119.20 Million ≈ $12.83 Million	Skr-37.58 Million ≈ $-4.04 Million	-0.315x	-74.80%
2018-12-31	Skr159.66 Million ≈ $17.18 Million	Skr-28.79 Million ≈ $-3.10 Million	-0.180x	+11.46%
2017-12-31	Skr110.70 Million ≈ $11.91 Million	Skr-22.55 Million ≈ $-2.43 Million	-0.204x	+24.73%
2016-12-31	Skr142.04 Million ≈ $15.29 Million	Skr-38.43 Million ≈ $-4.14 Million	-0.271x	+84.20%
2015-12-31	Skr21.98 Million ≈ $2.37 Million	Skr-37.65 Million ≈ $-4.05 Million	-1.712x	-162.87%
2014-12-31	Skr62.42 Million ≈ $6.72 Million	Skr-40.67 Million ≈ $-4.38 Million	-0.651x	+44.40%
2013-12-31	Skr15.73 Million ≈ $1.69 Million	Skr-18.43 Million ≈ $-1.98 Million	-1.172x	-127.13%
2012-12-31	Skr14.06 Million ≈ $1.51 Million	Skr-7.25 Million ≈ $-780.54K	-0.516x	+64.79%
2011-12-31	Skr3.31 Million ≈ $356.64K	Skr-4.86 Million ≈ $-522.58K	-1.465x	-1395.19%
2009-12-31	Skr-901.48K ≈ $-97.01K	Skr-101.99K ≈ $-10.98K	0.113x	--

About Enzymatica publ AB

ST:ENZY Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$57.47 Million

Skr534.02 Million SEK

Market Cap Rank

#21152 Global

#384 in Sweden

Share Price

Skr2.20

Change (1 day)

-4.35%

52-Week Range

Skr1.65 - Skr3.20

All Time High

Skr770.83